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Abstract
Patients with some types of cardiovascular disease are
prescribed anticoagulation therapy with Warfarin in order to 
control the ability of blood clotting. This work presents a co-
desgined mobile application, called Warfarin Guide, for a 
computer-assisted anticoagulant therapy. The application 
addresses the challenges that unexperienced patients may find 
when having to remember to regularly check their INR values 
and make temporary adjustments for INR value fluctuations 
that are not easy to interpret without direct medical advice.
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Introduction
Patients with some cardiovascular disease types, e.g., 
mechanical heart valves, are prescribed lifelong 
anticoagulation therapy with Warfarin to prevent 
thromboembolic complications. The intensity of the 
anticoagulation therapy is based on the International 
Normalized Ratio (INR) value. A low INR value indicates a 
risk of increased blood clotting which can cause life-
threatening conditions, while a high value of INR indicates a 
high risk of bleeding. Food intake (especially vitamin K-rich 
vegetables), alcohol consumption, physical exercise, illness 
and stress may also influence the INR values. Patients treated 
with Warfarin are recommended to self-monitor their INR 
values with a portable coagulometer device that samples 
whole blood obtained by fingerprick, and self-management of 
the Warfarin therapy. It might be difficult, in particular for 
unexperienced patients, to regularly check their INR values 
and make necessary changes in warfarin dosing based on the 
measured values, in light of previous studies which have 
reported low time within therapeutic INR range.
The aim of this project is to develop an easy-to-use mobile 
application for computer assisted anticoagulation therapy. The 
project is divided in two phases: 1) a co-design, 2) a usability 
test of the application and 3) a randomised control trial. This 
work presents the results of the first phase.
Methods
The co-design process was carried out with 8 students of the 
Master of Health and Social Informatics’ at the University of 
Agder (UiA), Norway and iteratively tested in the Usability 
laboratory at UiA with patients who were prescribed an 
anticoagulant therapy.
The Master students co-designed a non-functional prototype  
of the Warfarin Guide application (WGA),  and  the 
explanation of their prototype was recorded on camera. The 
application developers watched the recordings and 
implemented a working prototype. The prototype was iterated 
through 2 usability tests with 5 anticoagulant therapy patients. 
The first test included a cognitive walkthrough process with 
an individual interview after using the application. The second 
test targeted specific tasks of the refined userinterface.
Results
The co-design process allowed the Master students to create a 
non-functional prototype of the application, including 
different features based on their experience of working with 
patients prescribed with an anticoagulant therapy. The co-
design provided developers with a useful insight about what 
was important for end-users, prioritising meaningfulness of 
messages and user friendliness of the user interface (UI). The 
cognitive walkthrough was useful to understand, step by step, 
how patients interacted with the application in order to obtain 
the exact dose, keep track of their INR values and set up a 
reminder for next dosage intake. The usability tests helped to 
iteratively improve the UI. The individual interviews allowed 
the research team to understand the way that the WGA could 
address users’ needs.
Conclusions
Self-management medication for anticoagulation therapy 
presents two challenges to unexperienced patients: remember 
and maintain a regular monitoring of their INR values; and 
calculate an exact dosage intake adjusted to the nonuniform 
fluctuations of INR values. The co-designed WGA tested in 
the laboratory provided an up-to-date monitoring of INR 
values and an individualised calculation of dosage adjustment, 
including a valuable reminder function for medication intake 
and upcoming measurements. The adherence, effectiveness 
and benefits of the computer-assisted anticoagulant therapy 
will be clinically verified in a clinical randomised controltrial.
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